Start by Topic

11 research hubs
Featured image of post Tech Leaders’ Money in Biotech Reached Public Stocks First Through Acquisitions and Narratives: A Map of 94 Companies and a Review of U.S. and Korean Listed Companies

Tech Leaders’ Money in Biotech Reached Public Stocks First Through Acquisitions and Narratives: A Map of 94 Companies and a Review of U.S. and Korean Listed Companies

Of the 94 companies that received biotech investments from tech leaders, only 10 now trade under their own tickers. Private capital reached public markets first through acquisitions and narrative-driven multiples, while earnings remain unconfirmed. This analysis reviews second-quarter results and value relative to cash at U.S. listed companies, alongside evidence for overseas contracts at Korean listed companies.

Featured image of post Semiconductor Suppliers Rallied Sharply, but Only a Fraction of Large-Cap Selling Followed: Reviewing Entry Order Across the Value Chain

Semiconductor Suppliers Rallied Sharply, but Only a Fraction of Large-Cap Selling Followed: Reviewing Entry Order Across the Value Chain

Only part of the money leaving Samsung Electronics and SK hynix went to semiconductor suppliers. Prices moved sharply, but capital did not follow at the same scale, and pension funds, investment trusts, private funds, and foreign investors bought different stocks. This review compares GPUs, CPUs, CoWoS, memory, and Korean packaging, materials, equipment, and substrates on the same basis, then identifies where to look first.